Century Therapeutics, Inc.

IPSC ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
Assets
Cash & Equivalents $61.9M $58.4M $47.3M $84.3M $56.4M $27.2M
Accounts Receivable — — — — — —
Inventory — — — — — —
Total Current Assets $120.8M $194.1M $177.0M $319.7M $228.2M $78.8M
Property, Plant & Equipment $50.0M $62.1M $71.7M $82.8M $58.0M $15.4M
Goodwill — — — — — —
Intangible Assets (Excl. Goodwill) $34.2M $34.2M — — — —
Total Assets $223.7M $353.2M $360.7M $486.5M $437.4M $106.8M
Liabilities
Accounts Payable $4.8M $3.1M $2.7M $5.5M $7.6M $8.1M
Total Current Liabilities $20.2M $129.8M $17.8M $29.8M $15.7M $12.1M
Long-Term Debt — — — $3.7M $8.9M $9.6M
Total Liabilities $64.8M $191.9M $175.9M $183.8M $41.1M $33.4M
Stockholders' Equity
Retained Earnings $-791.9M $-782.3M $-655.8M $-519.1M $-388.2M $-292.3M
Total Stockholders' Equity $158.9M $161.4M $184.8M $302.7M $396.2M $-106.4M